Product category:
Manufacturing dealerships, agencies and acquisitions
News Release from: Smithers Rapra
Edited by the Manufacturingtalk Editorial
Team on 15 August 2005
Rapra and Icon form partnership
Rapra Technology, Europe's leading research and test centre for plastics and rubber, and Icon Polymer have formed a strategic partnership for serving the pharmaceutical industry.
Rapra Technology, Europe's leading research and test centre for plastics and rubber, and Icon Polymer have formed a strategic partnership for Icon's rubber products and components for the pharmaceutical industry Retford Headquartered Icon in the UK is one of the few companies worldwide who are able to supply rubber components into drug delivery systems
This article was originally published on Manufacturingtalk on 25 Apr 2002 at 8.00am (UK)
Related stories
Book covers costs spectrum of plastics processing
Cost Management in Plastics Processing - Strategies, Target, Techniques and Tools - examines issues from how costs are calculated, to the effective use of machines and labour.
Assessing the life of plastics materials
'Practical Guide to the Assessment of the Useful Life of Plastics' provides practical guidance on assessing the useful service life of plastics.
The partnership with Shawbury-based Rapra Technology will now further enable Icon to offer a 'one-stop-shop' and seamless service to its existing and potential customers.
Full analytical and laboratory testing facilities will now be part of the Icon package.
The technical services supplied by Rapra Technology will include extractable and leachable testing, deformulation, protocol and consultative services.
The partnership will also allow Icon and Rapra to share general capabilities and information and to arrange compliance with cGMP, FDA and MHRA approvals and protocols.
Icon project manager Anna Shaw says that: "Rapra Technology has over 85 years of generic rubber and plastics research expertise".
"We at Icon have over thirty years of manufacturing elastomer-based solutions for the pharmaceutical industry".
"Our strategic partnership will allow us to grow pharmaceutical rubber technology in line with the increased demand that is out there." To that end Icon offers a bespoke and tailored design capability to its clients; providing solutions for a wide range of applications.
Icon also facilitates projects from design conception to product delivery; producing CATIA design models generated in compliance with Global pharmaceutical specifications and protocol.
Rapra's technology manager, David Ingles, says that: "Icon has identified that one of the fundamental requirements for suppliers into this sector is the provision of top quality analytical data to support technical claims made for the products".
"This data is also needed to address the increasing regulatory requirement for sophisticated extractables data from elastomeric components and products".
"At Rapra we are ideally placed to provide a full and bespoke service to Icon in these matters".
"We are delighted to be partnering Icon in this manner.".
• Smithers Rapra: contact details and other news
• Email this article to a colleague
• Register for the free Manufacturingtalk email newsletter
• Manufacturingtalk Home Page
Search the Pro-Talk network of sites
